Durability of antidepressant response to repetitive transcranial magnetic stimulation: Systematic review and meta-analysis

Suhan Senova, Gonçalo Cotovio, Alvaro Pascual-Leone, Albino J. Oliveira-Maia

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background: The therapeutic options for treatment-resistant depression (TRD) encompass a range of neuromodulatory techniques, including repetitive transcranial magnetic stimulation (rTMS). While rTMS is safe and has documented short-term efficacy, durability of antidepressant effects is poorly established. Objective: Assess existing evidence regarding durability of rTMS-induced antidepressant response. Methods: We performed a systematic review of studies reporting antidepressant outcome measures collected three or more months after the end of an induction course of rTMS for depression. Among responders to the induction course, we used a meta-analytic approach to assess response rates at 3 (m3), 6 (m6) or 12 (m12) months after induction, and studied predictors of responder rates using meta-regression. Results: Nineteen studies published between 2002 and 2018 were included. Eighteen were eligible for analysis at m3 (732 patients) and m6 (695 patients) and 9 at m12 (247 patients). Among initial responders, 66.5% sustained response at m3 (95% CI = 57.1–74.8%, I2 = 27.6%), 52.9% at m6 (95% CI = 40.3–65%, I2 = 0%), and 46.3% at m12 (95% CI = 32.6–60.7%, I2 = 0%), in the absence of any major bias. Random-effects meta-regressions further demonstrated that a higher proportion of women, as well as receipt of maintenance treatment, predicted higher responder rates at specific time-points. Conclusions: rTMS is a durable treatment for depression, with sustained responder rates of 50% up to 1 year after a successful induction course of treatment. Maintenance treatment may enhance the durability of the antidepressant effects of rTMS, and should be considered in clinical practice, as well as systematically explored in future clinical trials.

Original languageEnglish
Pages (from-to)119-128
Number of pages10
JournalBrain Stimulation
Volume12
Issue number1
DOIs
Publication statusPublished - Jan 2019

Fingerprint

Transcranial Magnetic Stimulation
Antidepressive Agents
Meta-Analysis
Depression
Treatment-Resistant Depressive Disorder
Therapeutics
Outcome Assessment (Health Care)
Clinical Trials

Keywords

  • Depression
  • Durability
  • Meta-analysis
  • Relapse
  • Repetitive transcranial magnetic stimulation

Cite this

@article{f4896306a8ad410aa9820fc71ff35498,
title = "Durability of antidepressant response to repetitive transcranial magnetic stimulation: Systematic review and meta-analysis",
abstract = "Background: The therapeutic options for treatment-resistant depression (TRD) encompass a range of neuromodulatory techniques, including repetitive transcranial magnetic stimulation (rTMS). While rTMS is safe and has documented short-term efficacy, durability of antidepressant effects is poorly established. Objective: Assess existing evidence regarding durability of rTMS-induced antidepressant response. Methods: We performed a systematic review of studies reporting antidepressant outcome measures collected three or more months after the end of an induction course of rTMS for depression. Among responders to the induction course, we used a meta-analytic approach to assess response rates at 3 (m3), 6 (m6) or 12 (m12) months after induction, and studied predictors of responder rates using meta-regression. Results: Nineteen studies published between 2002 and 2018 were included. Eighteen were eligible for analysis at m3 (732 patients) and m6 (695 patients) and 9 at m12 (247 patients). Among initial responders, 66.5{\%} sustained response at m3 (95{\%} CI = 57.1–74.8{\%}, I2 = 27.6{\%}), 52.9{\%} at m6 (95{\%} CI = 40.3–65{\%}, I2 = 0{\%}), and 46.3{\%} at m12 (95{\%} CI = 32.6–60.7{\%}, I2 = 0{\%}), in the absence of any major bias. Random-effects meta-regressions further demonstrated that a higher proportion of women, as well as receipt of maintenance treatment, predicted higher responder rates at specific time-points. Conclusions: rTMS is a durable treatment for depression, with sustained responder rates of 50{\%} up to 1 year after a successful induction course of treatment. Maintenance treatment may enhance the durability of the antidepressant effects of rTMS, and should be considered in clinical practice, as well as systematically explored in future clinical trials.",
keywords = "Depression, Durability, Meta-analysis, Relapse, Repetitive transcranial magnetic stimulation",
author = "Suhan Senova and Gon{\cc}alo Cotovio and Alvaro Pascual-Leone and Oliveira-Maia, {Albino J.}",
year = "2019",
month = "1",
doi = "10.1016/j.brs.2018.10.001",
language = "English",
volume = "12",
pages = "119--128",
journal = "Brain Stimulation",
issn = "1935-861X",
publisher = "Elsevier",
number = "1",

}

Durability of antidepressant response to repetitive transcranial magnetic stimulation : Systematic review and meta-analysis. / Senova, Suhan; Cotovio, Gonçalo; Pascual-Leone, Alvaro; Oliveira-Maia, Albino J.

In: Brain Stimulation, Vol. 12, No. 1, 01.2019, p. 119-128.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Durability of antidepressant response to repetitive transcranial magnetic stimulation

T2 - Systematic review and meta-analysis

AU - Senova, Suhan

AU - Cotovio, Gonçalo

AU - Pascual-Leone, Alvaro

AU - Oliveira-Maia, Albino J.

PY - 2019/1

Y1 - 2019/1

N2 - Background: The therapeutic options for treatment-resistant depression (TRD) encompass a range of neuromodulatory techniques, including repetitive transcranial magnetic stimulation (rTMS). While rTMS is safe and has documented short-term efficacy, durability of antidepressant effects is poorly established. Objective: Assess existing evidence regarding durability of rTMS-induced antidepressant response. Methods: We performed a systematic review of studies reporting antidepressant outcome measures collected three or more months after the end of an induction course of rTMS for depression. Among responders to the induction course, we used a meta-analytic approach to assess response rates at 3 (m3), 6 (m6) or 12 (m12) months after induction, and studied predictors of responder rates using meta-regression. Results: Nineteen studies published between 2002 and 2018 were included. Eighteen were eligible for analysis at m3 (732 patients) and m6 (695 patients) and 9 at m12 (247 patients). Among initial responders, 66.5% sustained response at m3 (95% CI = 57.1–74.8%, I2 = 27.6%), 52.9% at m6 (95% CI = 40.3–65%, I2 = 0%), and 46.3% at m12 (95% CI = 32.6–60.7%, I2 = 0%), in the absence of any major bias. Random-effects meta-regressions further demonstrated that a higher proportion of women, as well as receipt of maintenance treatment, predicted higher responder rates at specific time-points. Conclusions: rTMS is a durable treatment for depression, with sustained responder rates of 50% up to 1 year after a successful induction course of treatment. Maintenance treatment may enhance the durability of the antidepressant effects of rTMS, and should be considered in clinical practice, as well as systematically explored in future clinical trials.

AB - Background: The therapeutic options for treatment-resistant depression (TRD) encompass a range of neuromodulatory techniques, including repetitive transcranial magnetic stimulation (rTMS). While rTMS is safe and has documented short-term efficacy, durability of antidepressant effects is poorly established. Objective: Assess existing evidence regarding durability of rTMS-induced antidepressant response. Methods: We performed a systematic review of studies reporting antidepressant outcome measures collected three or more months after the end of an induction course of rTMS for depression. Among responders to the induction course, we used a meta-analytic approach to assess response rates at 3 (m3), 6 (m6) or 12 (m12) months after induction, and studied predictors of responder rates using meta-regression. Results: Nineteen studies published between 2002 and 2018 were included. Eighteen were eligible for analysis at m3 (732 patients) and m6 (695 patients) and 9 at m12 (247 patients). Among initial responders, 66.5% sustained response at m3 (95% CI = 57.1–74.8%, I2 = 27.6%), 52.9% at m6 (95% CI = 40.3–65%, I2 = 0%), and 46.3% at m12 (95% CI = 32.6–60.7%, I2 = 0%), in the absence of any major bias. Random-effects meta-regressions further demonstrated that a higher proportion of women, as well as receipt of maintenance treatment, predicted higher responder rates at specific time-points. Conclusions: rTMS is a durable treatment for depression, with sustained responder rates of 50% up to 1 year after a successful induction course of treatment. Maintenance treatment may enhance the durability of the antidepressant effects of rTMS, and should be considered in clinical practice, as well as systematically explored in future clinical trials.

KW - Depression

KW - Durability

KW - Meta-analysis

KW - Relapse

KW - Repetitive transcranial magnetic stimulation

UR - http://www.scopus.com/inward/record.url?scp=85055033465&partnerID=8YFLogxK

U2 - 10.1016/j.brs.2018.10.001

DO - 10.1016/j.brs.2018.10.001

M3 - Article

VL - 12

SP - 119

EP - 128

JO - Brain Stimulation

JF - Brain Stimulation

SN - 1935-861X

IS - 1

ER -